InsidersTradesSigma
Track the 아이엠바이오로직스 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 아이엠바이오로직스 has recorded 7 reports. Market capitalisation: €258.3bn. The latest transaction was filed on 30 March 2026 (Purchase). Among the most active insiders: 아이엠엠인베스트먼트. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
아이엠바이오로직스 是一家在XKRX市场上市的健康和制药公司。它专注于开发创新的生物解决方案。